Opioid mechanisms and opioid drugs

Anaesthesia and Intensive Care Medicine

Volumn 9, Issue 1, 2008, Pages 33-37

  McDonald, John ^a   Lambert, David G ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

G protein coupled receptor; MOP DOP opioid receptor actions; NOP receptor antagonist

Indexed keywords

17 METHYLNALTREXONE; ADENYLATE CYCLASE; ALVIMOPAN; ANTISENSE OLIGONUCLEOTIDE; CYCLIC AMP; DELTA OPIATE RECEPTOR; DELTA OPIATE RECEPTOR AGONIST; DELTA OPIATE RECEPTOR ANTAGONIST; ENADOLINE; ENKEPHALINASE INHIBITOR; GUANINE NUCLEOTIDE BINDING PROTEIN; KAPPA OPIATE RECEPTOR; KAPPA OPIATE RECEPTOR AGONIST; MORPHINE; MU OPIATE RECEPTOR; MU OPIATE RECEPTOR AGONIST; NALOXONE; NOCICEPTIN; NOCICEPTIN RECEPTOR; NOCICEPTIN RECEPTOR AGONIST; NOCICEPTIN RECEPTOR ANTAGONIST; OPIATE DERIVATIVE; OPIATE PEPTIDE; OPIATE RECEPTOR; POTASSIUM CHANNEL; PROTEIN PRECURSOR; SPIRADOLINE; SPIRADOLINE MESILATE; VOLTAGE GATED CALCIUM CHANNEL;

ANALGESIC ACTIVITY; CLINICAL TRIAL; CONFUSION; CONSTIPATION; DEPERSONALIZATION; DIURESIS; DIZZINESS; DRUG DEPENDENCE; DRUG EFFICACY; DRUG POTENTIATION; DRUG RECEPTOR BINDING; DRUG SAFETY; DRUG TOLERANCE; DYSPHORIA; ENZYME INHIBITION; HUMAN; HYPERPOLARIZATION; KNOCKOUT MOUSE; NAUSEA; NOCICEPTION; NONHUMAN; OPIOID INDUCED EMESIS; PAIN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN SYNTHESIS INHIBITION; RECEPTOR DENSITY; RESPIRATION DEPRESSION; REVIEW; SEDATION; SIDE EFFECT; SIGNAL TRANSDUCTION; TISSUE DISTRIBUTION; UNSPECIFIED SIDE EFFECT; URINE VOLUME;

EID: 37449018632     PISSN: 14720299     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mpaic.2007.10.007     Document Type: Review

References (13)

1. Zollner C., and Stein C. Opioids. Handb Exp Pharmacol 177 (2007) 31-63
2. McDonald J., and Lambert D.G. Opioid receptors. Contin Educ Anaesth Crit Care Pain 5 (2005) 22-25
3. New D.C., and Wong Y.H. The ORL1 receptor: molecular pharmacology and signalling mechanisms. Neurosignals 11 (2002) 197-212
4. Mogil J.S., and Pasternak G.W. The molecular and behavioral pharmacology of the orphanin FQ/nociceptin peptide and receptor family. Pharmacol Rev 53 (2001) 381-415
5. Ananthan S. Opioid ligands with mixed mu/delta opioid receptor interactions: an emerging approach to novel analgesics. AAPS J 8 (2006) E118-E125
6. Wadenberg M.L. A review of the properties of spiradoline: a potent and selective kappa-opioid receptor agonist. CNS Drug Rev 9 (2003) 187-198
7. Walsh S.L., Strain E.C., Abreu M.E., and Bigelow G.E. Enadoline, a selective kappa opioid agonist: comparison with butorphanol and hydromorphone in humans. A review of the properties of spiradoline: a potent and selective kappa-opioid receptor agonist. Psychopharmacology (Berl) 157 (2001) 151-162
8. Stein C., Schafer M., and Machelska H. Attacking pain at its source: new perspectives on opioids. Nat Med 9 (2003) 1003-1008
9. Sinatra R.S. Peripherally acting mu-opioid-receptor antagonists and the connection between postoperative ileus and pain management: The anesthesiologist's view and beyond. J Perianesth Nurs 21 2A suppl (2006) S16-S23
10. Mollereau C., and Mouledous L. Tissue distribution of the opioid receptor-like (ORL1) receptor. Peptides 21 (2000) 907-917
11. Mogil J.S., Nessim L.A., and Wilson S.G. Strain-dependent effects of supraspinal orphanin FQ/nociceptin on thermal nociceptive sensitivity in mice. Neurosci Lett 261 (1999) 147-150
12. Kest B., Hopkins E., Palmese C.A., et al. Morphine tolerance and dependence in nociceptin/orphanin FQ transgenic knock-out mice. Neuroscience 104 (2001) 217-222
13. Ueda H., Inoue M., Takeshima H., and Iwasawa Y. Enhanced spinal nociceptin receptor expression develops morphine tolerance and dependence. J Neurosci 20 (2000) 7640-7647